In contrast with the results with the PDGFB-driven GBM model, there was no difference in survival in either males or females when Nf1-silenced GBMs were initiated using the RCAS-TVA system in Il1b-knockout versus control, WT mice (8). The gene discussed is NF1; the disease is glioblastoma.